Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Terheyden, P; Hofmann, MA; Weininger, M; Brocker, EB; Becker, JC.
Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma.
J Cancer Res Clin Oncol. 2007; 133(11):897-901 Doi: 10.1007/s00432-007-0251-8 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Becker Jürgen Christian
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
PURPOSE: The combination of the antiangiogenic antibody bevacizumab with standard chemotherapy has improved the prognosis in patients with metastastic colorectal cancer and other advanced cancers. The role of combined anti-VEGF and chemotherapy in metastastic melanoma is just starting to be elucidated. METHODS: We tested this notion in three patients with advanced and therapy-refractory melanoma. RESULTS: Interestingly, two patients achieved objective regressions after three courses of therapy; the third patient, albeit progressing demonstrated a pronounced liquid necrosis in bulky lymphnode metastasis. CONCLUSION: Further studies are warranted to scrutinize these impressive therapeutic effects on the combination of bevacizumab and chemotherapy in melanoma.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Angiogenesis Inhibitors - therapeutic use
Antibodies, Monoclonal - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Female -
Humans -
Lung Neoplasms - drug therapy Lung Neoplasms - secondary
Male -
Melanoma - drug therapy Melanoma - secondary
Middle Aged -
Skin Neoplasms - drug therapy Skin Neoplasms - pathology
Vascular Endothelial Growth Factor A - antagonists and inhibitors Vascular Endothelial Growth Factor A - immunology

Find related publications in this database (Keywords)
melanoma
metastases
therapy
angiogenesis
chemotherapy
© Med Uni Graz Impressum